ArticleAnnals of hematology2023

More than 2% circulating plasma cells as a prognostic biomarker in a large cohort of patients with newly-diagnosed multiple myeloma.

Mengru Tian et al.PubMed ↗Publisher ↗

No numbers read from the abstract.